Argenx to report half year 2024 financial results and second quarter business update on july 25, 2024

July 18, 2024 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on thursday, july 25, 2024 at 2:30 pm cet (8:30 am et) to discuss its half year 2024 financial results and provide a second quarter business update.
ARGX Ratings Summary
ARGX Quant Ranking